Perrigo Company plc
NYSE:PRGODrug Manufacturers - Specialty & Generic
-$0.20 today
- Market cap
- $2.35B
- Beta
- 0.52
- P/E (TTM)
- -0.8
- EPS (TTM)
- -$13.10
- Dividend yield
- 11.65%
Volume 2.57M
Average 2.96M
PRGO Net Margin
Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.
Perrigo Company plcNYSE: PRGO
Net Margin · Q2 FY2026 · quarter ended Jun 2026
Net margin widens to 7.3%
Net margin was 7.3% in Q2 FY2026, up 8.1 pp from a year earlier. On a trailing-twelve-month basis it was -41.9%, down 40.0 pp year over year. Over 3 fiscal years it narrowed by 30.4 pp.
Context
- Net margin widened in 1 of the last 3 fiscal years.
- FY2025 was the lowest level in the 4 fiscal years shown.
What to watch
Whether net margin reaches the consensus estimate from 2 analysts of 7.9% for the fiscal year ending Dec 2026, up from -33.5% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- 7.3%+48.4 pp QoQ
- Last fiscal yearDec 2025
- -33.5%-29.6 pp YoY
- LTMJun 2026
- -41.9%-40.0 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +8.1 pp | +6.5 pp | -1.6 pp |
| 1 year | -29.6 pp | +41.4 pp | +71.0 pp |
| 3 years | -30.4 pp | +42.2 pp | +72.6 pp |
| 5 years | +43.3 pp | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- -33.5%
- Year-over-year change
- -29.6pp
| Period | Period end | Net Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | -33.5% | -29.6pp |
| FY2024 | 2024-12-31 | -3.9% | -3.7pp |
| FY2023 | 2023-12-31 | -0.3% | +2.9pp |
| FY2022 | 2022-12-31 | -3.2% | -1.5pp |
| FY2021 | 2021-12-31 | -1.7% | — |
Net Margin vs competitors
How PRGO compares with its peers on the latest reported figures
- PRGO's LTM Jun 2026 net margin of -41.9% is the 8th highest of the 10 companies compared; the peer median is -13.2%.
- Its year-over-year change of -40.0 pp is the 8th highest of 9, against a peer median of +6.2 pp.
- Over three fiscal years its change of -30.4 pp compares with a peer median of +4.3 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Jun 2025 | 77.5% | +84.4 pp | +167.9 pp | |
| LTM Sep 2026 | 13.0% | +29.1 pp | -9.0 pp | |
| LTM Sep 2026 | -2.6% | +2.6 pp | -0.2 pp | |
| LTM Jun 2026 | -10.1% | -11.1 pp | +4.3 pp | |
| LTM Jun 2026 | -13.2% | -22.9 pp | -14.5 pp | |
| LTM Mar 2026 | -15.9% | +9.8 pp | +24.4 pp | |
HTFLHeartflow, Inc. Common Stock | LTM Sep 2026 | -33.1% | +44.3 pp | — |
| LTM Jun 2026 | -41.9% | -40.0 pp | -30.4 pp | |
| LTM Sep 2026 | -102.9% | -80.8 pp | +225.8 pp | |
| LTM Sep 2026 | -72563.2% | — | — | |
| Peer median (excluding PRGO) | -13.2% | +6.2 pp | +4.3 pp | |
Competitors are the stored peer set for PRGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 4.14B | 4.45B | 4.66B | 4.37B | 4.25B |
| Cost of Revenue | 2.72B | 3B | 2.98B | 2.83B | 2.76B |
| Gross Profit | 1.42B | 1.46B | 1.68B | 1.54B | 1.49B |
| Gross Margin | 34.2% | 32.7% | 36.1% | 35.3% | 35.1% |
| Research & Development | 122M | 123.1M | 122.5M | 112.2M | 95.4M |
| Selling, General & Admin | 1.11B | 1.21B | 1.27B | 1.11B | 526.5M |
| Operating Expenses | 1.01B | 1.38B | 1.53B | 1.43B | 1.15B |
| Depreciation & Amortization | 312.2M | 338.6M | 359.5M | 325.9M | 337.5M |
| EBITDA | 695.9M | 355.5M | 525M | 433M | (797.9M) |
| EBITDA Margin | 16.8% | 8.0% | 11.3% | 9.9% | -18.8% |
| Operating Income | 410.4M | 78.9M | 151.9M | 112.9M | 343.3M |
| Operating Margin | 9.9% | 1.8% | 3.3% | 2.6% | 8.1% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 125M | 156M | 173.8M | 187.8M | 162.5M |
| Other Income / Expenses | (151.7M) | (218M) | (160.2M) | (193.6M) | (1.64B) |
| Income Before Tax | 258.7M | (139.1M) | (8.3M) | (80.7M) | (1.3B) |
| Pre-Tax Margin | 6.3% | -3.1% | -0.2% | -1.8% | -30.5% |
| Income Tax Expense | 389.6M | (8.2M) | (3.9M) | 80M | 104.4M |
| Net Income | (68.9M) | (140.6M) | (12.7M) | (171.8M) | (1.43B) |
| Net Margin | -1.7% | -3.2% | -0.3% | -3.9% | -33.5% |
| EPS (Basic) | (0.98) | (0.97) | (0.09) | (1.25) | (10.29) |
| EPS (Diluted) | (0.98) | (0.97) | (0.09) | (1.25) | (10.29) |
| Weighted Avg Shares | 133.6M | 134.5M | 135.3M | 137.4M | 138.5M |
| Weighted Avg Shares (Diluted) | 133.6M | 134.5M | 135.3M | 137.4M | 138.5M |
Perrigo Company plc
NYSE:PRGO
Intrinsic Alpha fair value
Locked
Current Price
$16.94
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.